FDA issues recall of Tippy Toes baby food due to mold contamination

Long-term ingestion of patulin can cause immune suppression, nerve damage, headaches, fever and nausea, the FDA says.

FDA issues consumer notice for counterfeit Green Lumber dietary supplements

According to an alert by the FDA, there were a number of products shipped under the Green Lumber branding that contain ...

Cake Mix Recall Update as FDA Sets Most Serious Risk Level

This classification is used when the FDA finds a reasonable chance that exposure could cause serious harm or death.

FDA Declines to Review Moderna’s mRNA Flu Vaccine Application

Moderna said its new flu shot has been cleared for review in Australia, Canada and the European Union. It has asked to meet ...

Top FDA scientist explains why he quit after getting a promotion from RFK Jr.

Richard Pazdur, a longtime regulator, said politics risks outweighing science at the agency.

FDA moves to ban BHA — an additive used in processed foods such as meats and bread

The Food and Drug Administration on Tuesday took steps toward banning BHA, a food additive used in processed foods such as ...

Why the FDA blocked Moderna’s new flu shot

The head of the agency’s vaccine division, Vinay Prasad, has overruled pushback from career staffers.
MedPage Today on MSN

FDA Leader Accused of Sexual Harassment; RFK Jr.'s Toilet Comment; GLP-1s and Scurvy

Health news and commentary gathered by MedPage Today staff ...
Fierce Biotech

FDA rejects Disc's rare disease drug despite commissioner's voucher

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...

FDA Refuses to Review Moderna’s New Flu Shot

The flu vaccine is its first using mRNA technology for influenza.

FDA defends its decision to refuse review of Moderna's flu vaccine

By Mariam Sunny and Michael Erman Feb 11 (Reuters) - A U.S. Food and Drug Administration official on Wednesday defended the ...

FDA defends its decision to not review Moderna’s mRNA flu shot

The Food and Drug Administration on Wednesday defended its rejection of Moderna’s mRNA-based flu vaccine application, saying the company’s clinical trial design put patients at risk ...